Angiodynamics (ANGO) Operating Expenses (2010 - 2026)

Angiodynamics' Operating Expenses history runs 17 years deep, the most recent figure standing at $57.0 million for Q2 2026.

• Quarterly Operating Expenses rose 18.67% year-over-year to $57.0 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $214.8 million (up 8.68% YoY) and the FY2026 annual result came in at $214.8 million, up 8.68% from the prior year.
• Operating Expenses was $57.0 million for Q2 2026 at Angiodynamics, up from $54.4 million in the prior quarter.
• Across five years, Operating Expenses topped out at $242.4 million in Q1 2024 and bottomed at $43.9 million in Q1 2022.
• A 5-year average of $63.1 million and a median of $52.9 million in 2022 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2024 — Operating Expenses surged 390.4% — and 2025, when it sank 79.86%.
• Angiodynamics' Operating Expenses stood at $53.2 million in 2022, then climbed by 0.36% to $53.4 million in 2023, then fell by 4.46% to $51.0 million in 2024, then dropped by 0.18% to $50.9 million in 2025, then advanced by 11.9% to $57.0 million in 2026.
• Business Quant data shows ANGO's Operating Expenses at $57.0 million in Q2 2026, $54.4 million in Q1 2026, and $50.9 million in Q4 2025.